Press release
Evolving Market Trends In The Attention Deficit Hyperactivity Disorder Industry: JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR
Attention Deficit Hyperactivity Disorder
What Is the Expected Attention Deficit Hyperactivity Disorder Market Size During the Forecast Period?
In recent times, the market size for attention deficit hyperactivity disorder has experienced significant growth. It is projected to expand from $16.29 billion in 2024 to $17.43 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The historic growth is primarily due to the increasing rates of ADHD, a rise in ADHD cases among children, and a greater understanding of the disorder. Factors like increasing healthcare expenditure and government-led initiatives aimed at increased mental health awareness, have also contributed to its growth.
The market size for attention deficit hyperactivity disorder is predicted to experience robust expansion in the coming years, potentially reaching $22.59 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%. The predicted growth during the forecast period is linked to the increasing number of pediatric and adult patients undergoing treatment, sophisticated healthcare infrastructure, surging implementation of personalized medicine, recognition of mental health issues, and increased use of additives and preservatives in children's meals. The major trends for the forecast period consist of technological enhancements and innovative treatments, progression in diagnosis and treatment strategies, introduction of new therapeutic drugs, a shift towards non-stimulant drugs, and advancement in pharmaceutical treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21108
What Are the High-Growth Segments in the Attention Deficit Hyperactivity Disorder Market?
The attention deficit hyperactivity disorder market covered in this report is segmented -
1) By Type: Stimulants, Non-Stimulants
2) By Age Group: Children, Adults
3) By Gender: Male, Female
4) By Dosage Form: Tablets, Capsules, Other Dosage Forms
5) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy
Subsegments:
1) By Stimulants: Methylphenidate-based Medications, Amphetamine-based Medications, Mixed Amphetamine Salts, Dexmethylphenidate
2) By Non-Stimulants: Atomoxetine (Strattera), Guanfacine (Intuniv), Clonidine (Kapvay), Bupropion (Wellbutrin)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21108&type=smp
What Key Drivers Are Expected to Influence Future Attention Deficit Hyperactivity Disorder Market Growth?
The surge in personalized medicine adoption is expected to boost the advancement of the attention deficit hyperactivity disorder (ADHD) market. Personalized medicine, a technique in healthcare that modifies treatments based on a person's genetic, environmental, and lifestyle elements, is being embraced due to the progress in genomics technologies. These technologies allow for the customization of treatments considering a person's genetic make-up, thereby resulting in more specific and successful therapies. By taking into account a person's unique genetic, environmental and behavioral traits, ADHD plays a significant role in personalized medicine, enabling the design of customized treatment strategies, leading to more precise and effective interventions. For example, according to a study by the US-based non-profit organization, the Personalized Medicine Coalition (PMC) in February 2024, personalized medicines constituted over one-third of new FDA drug approvals for the fourth consecutive year in 2023. The FDA granted approval to 16 new personalized treatments for rare diseases (an increase from 6 in 2022), 7 cancer drugs and 3 for other diseases. As a result, the escalating adoption of personalized medicine is the catalyst for the growth of the attention deficit hyperactivity disorder market.
Which Companies Hold the Largest Share Across Different Attention Deficit Hyperactivity Disorder Market Segments?
Major companies operating in the attention deficit hyperactivity disorder market are Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, Adlon Therapeutics L.P.
What Attention Deficit Hyperactivity Disorder Market Trends Are Gaining Traction Across Different Segments?
Leading corporations in the ADHD market are emphasizing the development of innovative medicines such as extended-release tablets to advance treatment efficiency, patient cooperation, and offer prolonged symptom management. These tablets slowly release medicine over time, maintaining steady symptom control throughout the day with just one dose. This reduces the requirement for numerous dosages and enhances convenience, ensuring successful adherence to the treatment regimen for individuals with ADHD. For example, JAMP Pharma Group, a pharmaceutical company based in Canada, introduced Guanfacine XR, a generic version of Takeda Canada Inc.'s INTUNIV XR, in February 2022. This drug, meant for treating ADHD, is an extended-release form of guanfacine that operates by influencing certain receptors in the brain to enhance attention, impulse control, and hyperactivity. The medication is offered in several strengths (1 mg, 2 mg, 3 mg, and 4 mg) and is provided in a bottle of 100, thus allowing flexibility in treatment.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-global-market-report
What Are the Emerging Geographies for The Attention Deficit Hyperactivity Disorder Market Growth?
North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Attention Deficit Hyperactivity Disorder Market?
2. What is the CAGR expected in the Attention Deficit Hyperactivity Disorder Market?
3. What Are the Key Innovations Transforming the Attention Deficit Hyperactivity Disorder Industry?
4. Which Region Is Leading the Attention Deficit Hyperactivity Disorder Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Evolving Market Trends In The Attention Deficit Hyperactivity Disorder Industry: JAMP Pharma Group Expands ADHD Treatment Options With Launch Of Guanfacine XR here
News-ID: 4069583 • Views: …
More Releases from The Business Research Company
C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025?
There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion…
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025?
The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
More Releases for Attention
Attention! chilliapple becomes Laravel certified company
chilliapple is a leading web and app development agency in the UK that has been operating since 2008. With a large team of in-house consultants, designers, developers, and QA analysts, the agency specialises in a range of services. Whether you are looking for bespoke software development or updating existing code, they can provide you with innovative solutions.
They specialise in building online stores on several platforms like Magento, Shopify, PrestaShop,…
Attention-bias Modification Treatment App (ABMT)
Global Attention-bias Modification Treatment App Market Research Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. Delivery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe. The report proves to be indispensable when…
Attention Deficit Hyperactivity Treatment Disorder (ADHD) Market : A Market Surv …
Attention deficit hyperactivity disorder also known as hyperkinetic disorder/ neuropsychiatric disorder is one of the most common brain disorder characterized by symptoms of hyperactivity, inattention, and impulsivity. It is commonly observed in children above 12years age as compared to older population. The exact cause of the Attention Deficit Hyperactivity Disorder (ADHD) is not clear but, expected to be resulted due to improper functioning of the nervous system that led to…
Mining Industry Safety Attracts More Attention
A survey made on Wednesday by industrial software company Ventyx, a subsidiary of ABB, shows that mining industry safety is one of the three top concerns by mining executives, including employee safety, managing capital projects and maximising production effectiveness. This study makes the mining safety on the top position in mining industry.
The 2012 Worldwide Mining Survey analyzed new trends and shifting attitudes around workforces, capital investments and technology and…
ATTENTION EARTH!
It’s the year 2013, if you’re reading this Earth has shockingly survived the Mayan prediction and prophetic date of December 21st, 2012. Since this is being written in the past, it’s not certain what has happened to humankind. Did Earth collide with planet X? Or was the cataclysm of 2012 a positive physical and/or spiritual transformation for humanity. Be as it may, hopefully this day will mark the beginning of…
The Gift of Attention Deficit Disorder
“Attention Deficit Disorder (ADD/ADHD) is an evolutionary process not a disability,” asserted Dr. Kevin, author of “Managing the Gift of Your ADD/HD Child” on Lon Woodbury’s Internet Talk Radio Show “Parent Choices for Struggling Teens” on October 17, 2011 at LATalkRadio at http://www.latalkradio.com.
“By the mid-19th century, society started to transition from physical survival being a top priority to one with advancements that allowed more time to focus on improving…
